Krka Tovarna Zdravil D.D. 

€265.50
95
+€5.00+1.92% Friday 13:30

Statistics

Day High
265.5
Day Low
264
52W High
273
52W Low
224
Volume
0
Avg. Volume
0
Mkt Cap
8.71B
P/E Ratio
-
Dividend Yield
3.43%
Dividend
9.1

Upcoming

Dividends

3.43%Dividend Yield
Jul 26
€9.10
Jul 25
€8.25
Jul 24
€7.50
Jul 23
€6.60
Jul 22
€5.63
10Y Growth
13.13%
5Y Growth
12.72%
3Y Growth
11.3%
1Y Growth
10.3%

Financials

19.76%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.04BRevenue
403.24MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KRKG.VI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Krka in various therapeutic areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Krka's offerings in the global market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a leading generic and specialty pharmaceutical company, competing with Krka in the generics market.
Merck
MRK
Mkt Cap366B
Merck & Co. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Krka in several therapeutic areas.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a global healthcare company that produces pharmaceuticals and vaccines, directly competing with Krka in various markets.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie is a biopharmaceutical company that develops and markets therapies, competing with Krka in the areas of chronic diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that operates in pharmaceuticals and diagnostics, competing with Krka in the development and marketing of drugs.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company, competing with Krka in the discovery, development, and delivery of medicines.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, competing with Krka in various therapeutic areas.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Krka in developing and commercializing prescription medicines.

About

Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Show more...
CEO
Jože Colarič
Employees
13236
Country
Other
ISIN
SI0031102120
WKN
000903246

Listings

0 Comments

Share your thoughts

FAQ

What is Krka Tovarna Zdravil D.D. stock price today?
The current price of KRKG.VI is €265.50 EUR — it has increased by +1.92% in the past 24 hours. Watch Krka Tovarna Zdravil D.D. stock price performance more closely on the chart.
What is Krka Tovarna Zdravil D.D. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Vienna Exchange exchange Krka Tovarna Zdravil D.D. stocks are traded under the ticker KRKG.VI.
What is Krka Tovarna Zdravil D.D. market cap?
Today Krka Tovarna Zdravil D.D. has the market capitalization of 8.71B
What is Krka Tovarna Zdravil D.D. revenue for the last year?
Krka Tovarna Zdravil D.D. revenue for the last year amounts to 2.04B EUR.
What is Krka Tovarna Zdravil D.D. net income for the last year?
KRKG.VI net income for the last year is 403.24M EUR.
Does Krka Tovarna Zdravil D.D. pay dividends?
Yes, KRKG.VI dividends are paid annual. The last dividend per share was 9.1 EUR. As of today, Dividend Yield (FWD)% is 3.43%.
How many employees does Krka Tovarna Zdravil D.D. have?
As of September 06, 2026, the company has 13,236 employees.
In which sector is Krka Tovarna Zdravil D.D. located?
Krka Tovarna Zdravil D.D. operates in the Health & Wellness sector.
When did Krka Tovarna Zdravil D.D. complete a stock split?
The last stock split for Krka Tovarna Zdravil D.D. was on September 03, 2007 with a ratio of 10:1.
Where is Krka Tovarna Zdravil D.D. headquartered?
Krka Tovarna Zdravil D.D. is headquartered in Novo Mesto, Other.